Drostanolone Propionate
Drostanolone Propionate is a short-acting esterified form of drostanolone developed to provide rapid hormone availability following intramuscular administration.Drostanolone is a s…
- Dosage Form / Route Intramuscular Injection
- Drug Class Anabolic Androgenic Steroid (AAS)
Product Specifications
| Dosage Form / Route | Intramuscular Injection |
|---|---|
| Composition | Drostanolone Propionate (C₂₃H₃₆O₃) |
| Indications | Previously investigated for the treatment of selected breast cancers; currently limited clinical use in most countries |
| Drug Class | Anabolic Androgenic Steroid (AAS) |
| Chemical Formula | C₂₃H₃₆O₃ |
| Molecular Weight | 360.53 g/mol |
| Half-Life | Approximately 2–3 Days |
| Ester Type | Short-Acting Drostanolone Ester |
This page is for product information only. NEXON does not sell products online through this website.
Scientific Profile
Detailed information
Introduction
Drostanolone Propionate is a short-acting esterified form of drostanolone developed to provide rapid hormone availability following intramuscular administration.Drostanolone is a synthetic anabolic androgenic steroid structurally derived from dihydrotestosterone (DHT). Unlike testosterone, drostanolone cannot undergo aromatization to estrogen and exhibits pharmacological characteristics associated with DHT-derived compounds.The propionate ester allows rapid absorption from the intramuscular depot, resulting in early release of active drostanolone into systemic circulation.Compared with longer ester formulations, Drostanolone Propionate provides faster pharmacokinetic activity and earlier attainment of circulating hormone concentrations.Its pharmacological profile has made Drostanolone Propionate one of the most recognized DHT-derived anabolic steroids in both clinical investigation and endocrine pharmacology.
NEXON
History
Drostanolone was developed during pharmaceutical research investigating dihydrotestosterone derivatives with improved anabolic properties and reduced estrogenic activity.
Esterification with propionic acid produced Drostanolone Propionate, providing rapid absorption following intramuscular administration.
Historically, Drostanolone Propionate was investigated and utilized in selected medical settings, particularly in the treatment of certain forms of breast cancer before the introduction of newer therapeutic options.
Scientific investigation of drostanolone has contributed significantly to advances in:
- Dihydrotestosterone pharmacology
- Anabolic steroid chemistry
- Hormone-dependent cancer research
- Endocrine physiology
NEXON
Chemical Structure
Drostanolone Propionate consists of the drostanolone molecule esterified with propionic acid at the 17-beta hydroxyl position.
The propionate ester primarily modifies pharmacokinetic behavior without altering the biological activity of drostanolone after enzymatic hydrolysis.
- The propionate ester primarily influences:
- Absorption rate
- Release duration
- Plasma availability
- Pharmacokinetic characteristics
Following enzymatic cleavage of the ester bond, biologically active drostanolone becomes available to interact with androgen receptors throughout the body.
NEXON
Pharmacology
Following intramuscular administration, Drostanolone Propionate forms a short-duration depot within muscle tissue.
The propionate ester undergoes rapid enzymatic hydrolysis, releasing free drostanolone into systemic circulation.
Once released, drostanolone binds to androgen receptors located throughout multiple tissues including:
- Skeletal muscle
- Bone
- Bone marrow
- Connective tissue
- Skin
- Liver
- Reproductive tissues
Unlike testosterone and boldenone, drostanolone is a dihydrotestosterone derivative and is not aromatized into estradiol.
Conversion Pathway Enzyme Product Drostanolone → Hepatic Metabolites Hepatic Enzymes Inactive Metabolites Aromatization Aromatase No Significant Conversion
NEXON
Mechanism of Action
Drostanolone produces its biological effects primarily through activation of intracellular androgen receptors.
The biological process includes:
- Drostanolone enters target cells.
- Drostanolone binds to androgen receptors.
- The receptor-hormone complex becomes activated.
- The activated complex translocates into the cell nucleus.
- Interaction with androgen response elements occurs on DNA.
- Gene transcription is regulated.
- Cellular protein synthesis and tissue-specific physiological responses are influenced.
Activation of androgen receptors contributes to:
- Protein synthesis
- Nitrogen retention
- Muscle tissue maintenance
- Bone remodeling
- Red blood cell production
- Connective tissue physiology
- Endocrine regulation
NEXON
Pharmacodynamics
Drostanolone Propionate affects multiple physiological systems through androgen receptor signaling.
NEXON
Pharmacokinetics
Following intramuscular administration, Drostanolone Propionate forms a short-duration depot within muscle tissue.
The propionate ester undergoes rapid enzymatic hydrolysis, releasing active drostanolone into systemic circulation.
Compared with longer ester formulations, Drostanolone Propionate provides faster hormone availability, earlier peak plasma concentrations, and a shorter duration of biological activity.
NEXON
Physiological Effects
Normal drostanolone activity contributes to:
- Muscle Function
- Protein synthesis
- Nitrogen retention
- Maintenance of lean body tissue
- Muscle physiology
- Bone Health
- Bone remodeling
- Skeletal maintenance
- Bone metabolism
Clinical Applications
Drostanolone Propionate has previously been investigated for selected medical applications, particularly hormone- responsive breast cancer, and has also contributed to experimental endocrine research.
Clinical evaluation may include:
- Medical history
- Physical examination
- Laboratory assessment
- Individual pharmacological evaluation
Historical and investigational applications include:
- Hormone-responsive breast cancer
- Endocrine pharmacology
- Protein metabolism research
- Androgen receptor research
NEXON
Safety Considerations
Drostanolone therapy requires individualized medical evaluation and regular monitoring.
Important considerations include:
- Cardiovascular health
- Blood parameters
- Endocrine function
- Liver and kidney function
- Lipid profile
- Individual physiological response
NEXON
Potential Adverse Effects
Possible adverse effects may include:
- Endocrine Effects
- Suppression of endogenous testosterone production
- Hormonal imbalance
- Alterations in endocrine function
- Dermatological Effects
- Acne
- Increased skin oil production
- Hair loss in genetically predisposed individuals
- Cardiovascular Effects
- Changes in lipid profile
- Increased hematocrit
- Blood pressure alterations
- Reproductive Effects
- Reduced fertility
- Suppression of spermatogenesis
- Hormonal suppression
NEXON
Contraindications
Condition Reason Prostate Cancer Potential androgen sensitivity Male Breast Cancer Hormone-sensitive condition Pregnancy Risk of fetal virilization Severe Cardiac, Hepatic or Renal Disease Requires specialist evaluation Known Hypersensitivity Risk of allergic reaction
NEXON
Drug Interactions
Potential interactions may occur with:
Anticoagulants Drostanolone may influence anticoagulant response and require monitoring.
Antidiabetic Medications Changes in glucose metabolism may alter therapeutic requirements.
Corticosteroids Combined administration may influence fluid balance and metabolic parameters.
Other Hormonal Therapies Combined hormonal therapy requires professional medical supervision.
NEXON
Laboratory Monitoring
Laboratory Test Purpose CBC Assess blood parameters
Hematocrit Monitor red blood cell concentration
Hemoglobin Evaluate erythropoiesis
Liver Function Tests Assess hepatic health
Kidney Function Tests Evaluate renal function
Lipid Profile Monitor cardiovascular risk markers
Total Testosterone Evaluate endocrine status
Estradiol (E2) Assess hormonal balance
PSA (When Appropriate) Monitor prostate health
NEXON
Storage & Stability
- Store according to official product labeling.
- Protect from excessive heat and direct sunlight.
- Do not freeze.
- Maintain original packaging integrity.
- Keep away from children.
- Inspect packaging before use.
NEXON
Product Authenticity
Every genuine NEXON product should include appropriate quality verification features.
Authentication may include:
- Batch number tracking
- Manufacturing information
- Expiration date verification
- QR authentication system
- Authorized distribution verification
emphasizes transparency, traceability, and product quality control.
NEXON
Frequently Asked Questions
What is Drostanolone Propionate? Drostanolone Propionate is a short-acting esterified form of drostanolone designed to provide rapid hormone availability following intramuscular administration.
How is Drostanolone Propionate different from Drostanolone Enanthate? Drostanolone Propionate provides faster absorption and a shorter duration of activity, whereas Drostanolone Enanthate provides slower release and prolonged hormone availability.
Does Drostanolone Propionate convert to estrogen? No. Drostanolone is a dihydrotestosterone (DHT) derivative and is not considered a substrate for aromatase, therefore it does not undergo meaningful conversion to estradiol.
Why are drostanolone esters used? Esterification modifies the pharmacokinetic profile of drostanolone by controlling hormone release and influencing the duration of biological activity.
Was Drostanolone Propionate used clinically? Yes. Drostanolone Propionate was previously investigated and used in selected medical settings, particularly for certain hormone-responsive breast cancers, before newer treatment options became available.
NEXON
Quality Commitment
is committed to maintaining high standards of manufacturing quality, product consistency, traceability, and scientific transparency.
Through quality control systems, authentication procedures, and responsible information sharing, NEXON aims to provide reliable pharmaceutical products and educational resources for healthcare professionals and informed users.
NEXON